Why the study?
Cardiogenic shock mortality remains high, partly due to delayed diagnosis from gradual onset and nonspecific symptoms.
Does a machine learning algorithm using continuous electronic health record data accurately predict the development of cardiogenic shock in patients hospitalized with acute decompensated heart failure?
Does a machine learning algorithm using continuous electronic health record data accurately predict the development of cardiogenic shock in patients hospitalized with acute decompensated heart failure?
Answers are grounded in this paper and cite their sources.
A machine learning algorithm using routinely collected EHR data can predict cardiogenic shock in acute heart failure patients with a median lead time of 1.7 days before clinical diagnosis, potentially allowing for earlier, tailored interventions.
Objective: Despite technological and treatment advancements over the past two decades, cardiogenic shock (CS) mortality has remained between 40-60%. A number of factors can lead to delayed diagnosis of CS, including gradual onset and nonspecific symptoms. Our objective was to develop an algorithm that can continuously monitor heart failure patients, and partition them into cohorts of high- and low-risk for CS. Methods: We retrospectively studied 24,461 patients hospitalized with acute decompensated heart failure, 265 of whom developed CS, in the Johns Hopkins Healthcare system. Our cohort identification approach is based on logistic regression, and makes use of vital signs, lab values, and medication administrations recorded during the normal course of care. Results: Our algorithm identified patients at high-risk of CS. Patients in the high-risk cohort had 10.2 times (95% confidence interval 6.1-17.2) higher prevalence of CS than those in the low-risk cohort. Patients who experienced cardiogenic shock while in the high-risk cohort were first deemed high-risk a median of 1.7 days (interquartile range 0.8 to 4.6) before cardiogenic shock diagnosis was made by their clinical team. Conclusions: This risk model was able to predict patients at higher risk of CS in a time frame that allowed a change in clinical care. Future studies need to evaluate if CS analysis of high-risk cohort identification may affect outcomes.
No takes yet. Share an insight, caveat, or question.
Rahman et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: